Aldevron serves the biotechnology industry with custom production of nucleic acids and proteins.
Thousands of clients use Aldevron-produced plasmids, RNA and gene editing enzymes for projects ranging from research and clinical trials to commercial applications. The Company specializes in GMP manufacturing and is known for inventing the GMP-Source quality system.
The Company was acquired by Danaher Corporation (NYSE: DHR) in August 2021.
Sector
Healthcare | Life Science Tools, Pharma / Pharma Services
Investment Year
2017
Status
Past | Acquired by Danaher Corporation (NYSE: DHR)
Headquarters
Fargo, ND
News
June 17, 2021